Skip to main content
SpringerLink
Log in

Confounding factors for variation of clozapine plasma levels: drug interactions with proton pump inhibitor or infectious etiologies?

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mookhoek E, Loonen (2004) Retrospective evaluation of the effect of omeprazole on clozapine metabolism. Pharm World Sci 26:180–182

    Article  PubMed  CAS  Google Scholar 

  2. Aronson JK (2006) Clozapine. In: Meyler’s side effects of drugs The international encyclopedia of adverse drug reactions and interactions, 15th edn. Oxford, United Kingdom, pp 823-841

  3. Jaquenoud Sirot E, Knezevic B, Morena GP, Harenberg S, Oneda B, Crettol S et al (2009) ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine. J Clin Psychopharmacol 29:319–326

    Article  PubMed  CAS  Google Scholar 

  4. Andersson T, Hassan-Alin M, Hasselgren G, Röhss K (2001) Drug interactions studies with esomeprazole, the (S)-isomer of omeprazole. Clin Pharmacokinet 40(7):523–37

    Article  PubMed  CAS  Google Scholar 

  5. Andersson T, Miners JO, Veronese ME, Tassaneeyakul W, Tassaneeyakul W, Meyer UA et al (1993) Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism. Br J Clin Pharmacol 36:521–530

    PubMed  CAS  Google Scholar 

  6. Frick A, Kopitz J, Bergemann N (2003) Omeprazole reduces clozapine plasma concentrations: A case report. Pharmacopsychiatry 36:121–12

    Article  PubMed  CAS  Google Scholar 

  7. Haack MJ, Bak ML, Beurskens R, Maes M, Stolk LM, Delespaul PA (2003) Toxic rise of clozapine plasma concentrations in relation to inflammation. Eur Neuropsychopharmacol 13:381–385

    Article  PubMed  CAS  Google Scholar 

  8. Pfuhlmann B, Hiemke C, Unterecker S, Burger R, Schmidtke A, Riederer P et al (2009) Toxic clozapine serum levels during inflammatory reactions. J Clin Psychopharmacol 29:392–394

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Pharmacologie Clinique, Centre midi-pyrénées de PharmacoVigilance (CRPV, de Pharmacoépidémiologie et d’informations sur le Médicament, EA 369, faculté de Médecine, 37 Allées Jules Guesde, 31000, Toulouse, France

    Sophie Wagner, Jean Louis Montastruc & Haleh Bagheri

  2. Department of Psychiatry, Centre Hospitalier Gérard Marchant, 31057, Toulouse cedex, France

    M. G. Varet-Legros

  3. Department of Pharmacy, Centre Hospitalier Gérard Marchant, 31057, Toulouse Cedex, France

    Claudine Fabre

Authors
  1. Sophie Wagner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. G. Varet-Legros
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Claudine Fabre
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jean Louis Montastruc
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Haleh Bagheri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Haleh Bagheri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wagner, S., Varet-Legros, M.G., Fabre, C. et al. Confounding factors for variation of clozapine plasma levels: drug interactions with proton pump inhibitor or infectious etiologies?. Eur J Clin Pharmacol 67, 533–534 (2011). https://doi.org/10.1007/s00228-010-0925-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-010-0925-z

Keywords

Search

Navigation